An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)

Allakos Investigational Site 216-025, New York

Allakos Investigational Site 216-021, Philadelphia

Allakos Investigational Site 216-050, Winston-Salem

Allakos Investigational Site 216-020, Chapel Hill

Allakos Investigational Site 216-048, Durham

Allakos Investigational Site 216-027, Edgewater

Allakos Investigational Site 216-056, Jacksonville

Allakos Investigational Site 216-013, Miami

Allakos Investigational Site 216-063, Brandon

Allakos Investigational Site 216-053, New Port Richey

Allakos Investigational Site 216-068, Birmingham

Allakos Investigational Site 216-002, Huntsville

Allakos Investigational Site 216-006, Chattanooga

Allakos Investigational Site 216-003, Chattanooga

Allakos Investigational Site 216-011, Chattanooga

Allakos Investigational Site 216-062, Kingsport

Allakos Investigational Site 216-044, Mentor

Allakos Investigational Site 216-031, Cincinnati

Allakos Investigational Site 216-028, Cincinnati

Allakos Investigational Site 216-005, Rochester

Allakos Investigational Site 216-007, Chicago

Allakos Investigational Site 216-042, Kansas City

Allakos Investigational Site 216-001, Crowley

Allakos Investigational Site 216-022, Austin

Allakos Investigational Site 216-034, Aurora

Allakos Investigational Site 216-055, Sandy City

Allakos Investigational Site 216-030, Salt Lake City

Allakos Investigational Site 216-039, Ogden

Allakos Investigational Site 216-035, Phoenix

Allakos Investigational Site 216-045, Reno

Allakos Investigational Site 216-014, Santa Monica

Allakos Investigational Site 216-032, Chula Vista

Allakos Investigational Site 216-038, Tustin

Allakos Investigational Site 216-049, Walnut Creek

Allakos Investigational Site 216-064, Spokane

Allakos Investigational Site 216-026, Boston

Allakos Investigational Site 216-052, Boston

Allakos Investigational Site 216-051, Boston